DePaul University

Data scientists in Chicago fill in gaps on race, ethnicity in COVID-19 testing

DePaul University researchers use U.S. census data to impute missing data
26-Oct-2020 3:15 PM EDT, by DePaul University

Newswise — CHICAGO — Thousands of people are being tested for COVID-19 each day, but collecting complete demographic information, including race and ethnicity, has proven difficult. Data science researchers at DePaul University have stepped up in Chicago to help public health officials fill in this missing information. Their work imputing data — replacing missing information with predicted values — brought down the category of “unknown” race in COVID-19 tests in Chicago from 47% to 11%.

“This information is essential for understanding inequities with COVID-19,” said Fernando De Maio, professor of sociology and founding co-director of the Center for Community Health Equity at DePaul. Whether individuals are not reporting this information or clinicians are not collecting it, De Maio said this has been a local and national issue since the onset of the pandemic. “Everyone is struggling with missing data, but from what is already available, we know that the burden has been carried in disproportionate ways by minoritized and marginalized communities” De Maio said.

Missing data deepens inequity

When the Chicago Department of Public Health (CDPH) put out a call for assistance with this problem in April, faculty in DePaul’s College of Computing and Digital Media volunteered to help. Data science professor Daniela Stan Raicu and her research team at the Center for Data Science used an algorithm to analyze U.S. census data and available demographic information. They are able to predict an individual in Chicago’s race and ethnicity with 81% accuracy, according to Raicu. The team also developed a mobile application that allows city officials to easily and securely input the data with missing values.

“This was our way to help during the pandemic,” said Raicu, who also serves as associate provost for research at DePaul.

The results of DePaul’s data imputation process provided public health officials with “a more complete understanding of the impact of racial inequities within the COVID-19 epidemic in Chicago,” said Margarita Reina, a senior epidemiologist at the Chicago Department of Public Health. “By filling in the missing race/ethnicity data of those testing for COVID-19, CDPH and the city’s Racial Equity Rapid Response Team will be able to better pinpoint and prioritize testing, PPE distribution, community education and stakeholder engagement in our overall COVID response. This was not strictly an epidemiological exercise,” Reina emphasized.

Deep racial segregation in Chicago neighborhoods is part of what made the predictive analytics possible, explained De Maio. “We had someone’s last name and we had the address of their residence. With just those two pieces of information, we can predict their race and ethnicity with a very high degree of accuracy,” De Maio said. 

Collaboration closes gaps

DePaul’s Center for Data Science director Raicu recruited graduate students Hao Wu and Ian Wang to work with the data. Faculty member Ilyas Ustun, a professional lecturer in DePaul’s School of Computing, worked closely with them to develop an application that would make it easy for public health officials to input daily totals. The researchers used the Bayesian Improved Surname Geocoding method to predict patients’ unreported racial information based on their surname and geocoding.

“As a data scientist, I have been working in medical informatics and biology, but not public health. This was a way for me to take my research in a new direction,” Raicu said.

First, the team tested their algorithm for accuracy by using data for which the race and ethnicity of an individual was known. For the second part of validation, Ustun connected with researcher C. Scott Smith of DePaul’s Chaddick Institute for Metropolitan Development. “We worked together to see how sensitive the model was at various geographic scales,” said Smith, assistant director of the Chaddick Institute.

Then it was time to hand the app over to public health officials and make sure it worked for them.

“City epidemiologists and public health officials know the zip codes very well, and could confirm that the process made sense. The collaboration also led to conversations about how this new information could change what we know about how the virus is moving through the city,” Smith said.

New directions in research

As an expert in urban studies and geographic information systems, Smith’s research had largely focused on transportation and urban planning. He has found the pivot to assisting with public health research during the pandemic to be rewarding.

“The pandemic is affecting many different sectors and facets of our lives, including urban planning. We now see that transportation has played a key role in coronavirus-related health outcomes, from access to testing facilities to how urban design impacts probabilities of transmission. That's something we're looking at now,” Smith said.

Looking ahead, the researchers are seeking ways to expand the application so it can be used in other cities. So far, DePaul has done this work with seed funding from its College of Computing and Digital Media.

“We’re happy to help and it’s good that we can, but it’s also a sign of our nation’s under-funded public health system,” De Maio said. “And while we at DePaul have come up with a very practical solution, it doesn't fix the underlying problem. We need to do a better job of funding critical public health infrastructure. And we need to do more to make sure that equity-focused data analysis is always a priority,” he said.  

Researchers will present on this and other topics at the Nov. 6 Health Equity and Social Justice Conference, presented by DePaul University’s Master of Public Health Program and the Center for Community Health Equity. The conference is free and will be held on Zoom this year. In its 13th year, the conference aims to bring together community voices, share best practices, and provide a forum for organizations in the Chicagoland area to engage in lively, solution-oriented discussions at a time when many of are separated by remote work. Learn more and RSVP at


Filters close

Showing results

110 of 4156
Newswise: Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
23-Nov-2020 5:20 PM EST
Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
University of California San Diego

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread. New research suggests that that those suffering from economic hardships are less likely comply with new stay-at-home orders; however these same U.S. residents would be more likely to adhere to the new public health guidelines if their households received stimulus funds.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 9:15 AM EST Released to reporters: 30-Nov-2020 2:30 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 9:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded covid-19-update-surge-preparedness-vaccine-distribution
Released: 30-Nov-2020 2:20 PM EST
COVID-19 Update: Surge Preparedness, Vaccine Distribution

With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system's leaders say Cedars-Sinai is prepared.

Released: 30-Nov-2020 1:20 PM EST
Rethink COVID-19 infection control to keep primary schools open this winter, governments urged

An urgent rethink of infection control policies to keep COVID-19 infection at bay in schools is needed if primary schools are to be kept open this winter, and the knock-on effects on their families avoided, argue children's infectious disease specialists in a viewpoint, published online in the Archives of Disease in Childhood.

Newswise: Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Released: 30-Nov-2020 12:45 PM EST
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health

Don’t Delay Your Care – Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care

Released: 30-Nov-2020 12:10 PM EST
Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
University of Leeds

Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus.

Released: 30-Nov-2020 11:30 AM EST
More than one-third of children with COVID-19 show no symptoms: study
University of Alberta Faculty of Medicine & Dentistry

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

Newswise: Promising lab results in quest to find naturally occurring anti-COVID therapies
24-Nov-2020 5:35 PM EST
Promising lab results in quest to find naturally occurring anti-COVID therapies
University of Alabama Huntsville

So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 have shown efficacy in ongoing first-batch testing at the University of Tennessee Health Science Center’s Regional Biocontainment Laboratory (UTHSC RBL) that’s the next step in the process to becoming a drug.

Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.

Showing results

110 of 4156